Gilead Sciences - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeGilead Sciences
Gilead Sciences logo

Gilead Sciences

0 followers

GILD

Performance

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company focused on discovering, developing, and delivering medicines across virology, oncology, and inflammation to improve global health. The company emphasizes HIV, viral hepatitis, liver disease, cancer, and inflammatory conditions, with a pipeline spanning multiple therapeutic areas and a global presence. It highlights investments in research, patient access, and responsible corporate initiatives to advance health equity worldwide. Headquartered in Foster City, California, Gilead operates internationally to bring breakthrough therapies to patients around the world.

Recent News

Recent Deals

Key Team Members

Flavius Martin, MD

Executive Vice President, Research

Dietmar Berger, MD, PhD

Chief Medical Officer

Andrew Dickinson

Chief Financial Officer

Daniel O’Day

Chairman and Chief Executive Officer, Gilead Sciences

Stacey Ma

Executive Vice President, Pharmaceutical Development and Manufacturing

Key Facts

HQ Location

Foster City, United States

Founded

1987

Employees

over-10K

Status

Public

Website

https://gilead.com